Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Centene

Are Wall Street Analysts Predicting Centene Stock Will Climb or Sink?

Centene's remarkable run has earned investors handsome returns over the past year, yet Wall Street maintains moderately optimistic outlook on the stock.

Barchart

Centene's Quarterly Earnings Preview: What You Need to Know

Centene is set to announce its second-quarter earnings next month, and Wall Street expects a high triple-digit surge in its profits.

Barchart

Is Centene Stock Outperforming the Dow?

As Centene has notably outperformed the Dow recently, analysts remain moderately optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Wall Street Bullish or Bearish on Centene Stock?

Though Centene has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

The youngest-ever female Fortune 500 CEO is reinventing the largest Medicaid insurer amid funding cuts and rising costs

Also: All the news and watercooler chat from Fortune.

Fortune

The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strong

Centene CEO Sarah London is using AI, predictive algorithms, and affordable housing to prove government-sponsored health care can deliver strong results.

Fortune

Obamacare’s Slow Death Is Debilitating Centene Stock

Centene is reeling from the expiration of enhanced Obamacare subsidies that have triggered massive enrollment losses and a steep selloff in its shares.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Are Wall Street Analysts Bullish on Centene Stock?

Centene has underperformed the broader market over the past year, and analysts remain cautious about the stock’s prospects.

Barchart

Centene Earnings Preview: What to Expect

Centene is scheduled to report its fourth-quarter results shortly, with analysts projecting a triple-digit decline in its earnings.

Barchart

Is Centene Stock Underperforming the S&P 500?

As Centene has lagged behind the S&P 500 Index over the past year, analysts are cautious about the stock’s prospects.

Barchart

Trump reportedly seeks to extend ACA subsidies as affordability push finds common ground with Mamdani; Centene, Oscar shares jump

Centene, which is a top participant in public health exchanges, jumped 8%, Molina Healthcare rallied 5%, and Oscar Health soared 24%.

Fortune

What Are Wall Street Analysts' Target Price for Centene Stock?

Centene has significantly underperformed the broader market and the healthcare services space over the past year, and analysts remain cautious about the stock’s prospects.

Barchart

Centene Rebounds With Strong Q3 Results, Optimistic 2025 Forecast

US healthcare insurance provider Centene Corporation (NYSE:CNC) stock surged on Wednesday after reporting a third-quarter 2025 adjusted earnings of 50 cents, beating the consensus loss of 14 cents per share, down from $1.62 a year ago.

Benzinga

Centene And Oscar Health Stocks Sink After Molina Warning

U.S. healthcare insurance providers Centene Corporation (NYSE:CNC) and Oscar Health Inc. (NYSE:OSCR) stock are trading lower as their peer Molina Healthcare Inc. (NYSE:MOH) reported disappointing annual guidance.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

Exclusive: Trump judicial nominee "indefinitely" stalled by criminal probe

"Guard is still qualified and the White House wants to fill this spot," one of the sources said.

Barchart

What You Need To Know Ahead of Centene's Earnings Release

Centene is set to release its third-quarter results by the end of this month, and analysts expect a massive decline in profitability.

Fortune

Centene stock uncertainty as ACA subsidy expiration looms: What investors need to know about rising medical costs and 2026 Marketplace risk

Centene’s recent stock drop is closely linked to a combination of higher-than-expected medical costs amid challenging trends in the Affordable Care Act market and anticipation of the scheduled end to enhanced subsidies.

Benzinga

What's Going On With Centene Stock On Thursday?

Centene Corp (NYSE:CNC) stock is rallying Thursday after the insurer confirmed its fiscal 2025 outlook of roughly $1.75 adjusted EPS—beating Wall Street's $1.69 consensus—despite having pulled prior guidance in July over preliminary actuarial data concerns.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

How Is Centene’s Stock Performance Compared to Other Healthcare Stocks?

Centene has significantly underperformed the broader healthcare space over the past year, and analysts remain cautious about the stock’s prospects.

Benzinga

Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers

Cigna Group’s (NYSE:CI) Evernorth Health Services announced on Tuesday a $3.5 billion investment in Shields Health Solutions, a specialty pharmacy management company.

Barchart

Centene Stock: Is Wall Street Bullish or Bearish?

Centene has significantly underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Benzinga

Centene Clocks First Quarterly Loss In 13 Years, Stock Volatile (UPDATED)

Editor’s Note: The story has been updated with executive comment and stock price change

Benzinga

This Republican Lawmaker Sold Shares In Centene Days Before Advancing Trump's 'Big, Beautiful Bill' With Medicaid Cuts: Report

A Republican lawmaker is facing scrutiny after selling shares in Medicaid provider Centene Corp. (NYSE:CNC) just days before voting to advance legislation that included significant cuts to Medicaid.

Benzinga

Centene Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Centene Corporation (NYSE:CNC) will release earnings results for the second quarter before the opening bell on Friday, July 25.

Benzinga

Centene, Cigna, Others Drop As Molina's Results Rattle Sector

Molina Healthcare Inc. (NYSE:MOH) missed Wall Street expectations in its second-quarter earnings report Wednesday, triggering a selloff across the healthcare insurance sector.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.